20Dec
16Dec
New Research Study Shows Efficacy of Sustained Acoustic Medicine as Add-on Therapy in Treating Sport-Related Injuries and Returning Athletes to Play
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, was recently evaluated in a research study published in the Global Journal of Orthopedics Research, which measured the effectiveness of SAM treatment to reduce pain and improve function in athletes in conjunction with traditional therapies following sports-related musculoskeletal injuries. Read more >>
15Dec
TetraGenetics Announces Discovery of Functional Antibodies Against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference
TetraGenetics, a biopharmaceutical company developing novel antibody therapeutics for ion-channel mediated disorders, announced today that they will be presenting news of the discovery of functional antibodies against Nav1.8 at the Antibody Engineering & Therapeutics Virtual Conference taking place Dec 14th – 16th.
15Dec
Knipbio – Massachusetts start-up is developing an innovative way to feed fish and crustaceans sustainably.
By 2050, there will be about 2 billion more mouths to feed, which means the global demand for food will rise by nearly 40% in the next 30 years. As the population increases, so does the demand for protein. “Aquaculture has the potential to meet all of mankind’s protein needs,” says Larry Feinberg, the cofounder of KnipBio. Read more >>
11Dec
The whole thing is surreal’: Founder of Framingham-based DetraPel makes Forbes 30 Under 30 list
David Zamarin, founder of Framingham-based DetraPel, was named to the Class of 2021 Forbes 30 Under 30 list. DetraPel Inc., a provider of safer chemicals and consumer products, switched much of its manufacturing capabilities with a pivot to sanitizing and disinfecting products at the beginning of the COVID-19 pandemic. Read more >>
11Dec
Wolf Administration Highlights Development of Promising New Drug Candidate to Treat COVID-19
On Wednesday, Department of Community and Economic Development (DCED) Deputy Secretary Steve D’Ettorre and Ben Franklin Technology Partners Innovation Works Chief Executive Officer Richard Lunak joined Teresa Whalen, CEO of Pittsburgh-based CytoAgents, to highlight the development of a new COVID-19 treatment. “This exciting new development was made possible by the strong partnerships the Wolf Administration has fostered with our Ben Franklin Technology Partners and the companies they support, like CytoAgents,” said D’Ettorre. Read more >>
10Dec
Pittsburgh-based company behind ‘promising’ new COVID-19 treatment
On Wednesday, the Wolf Administration plans to highlight what it calls in a news advisory a “promising new drug candidate to treat COVID-19.” The Department of Community and Economic Development will announce that Pittsburgh-based biotechnology company CytoAgents has begun its Phase 1 clinical trial for COVID-19 treatment. Read more >>
10Dec
All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the National Institutes of Health, announces that the SAM family of medical ultrasound device has received positive reviews and feedback from professional athletes across a number of different sports and disciplines. The medical device's ability to provide relief from muscle injury and pain showcases SAM's ability to deal with the physical rigors of professional sports and is perfect for home use...
10Dec
ClassLink and Scrible Partnership Demonstrates the Benefits of Integrated Technology for School Districts
As easy access to digital resources grows increasingly critical to learning, the new ClassLink and Scrible partnership demonstrates how interoperability and open standards support remote and hybrid learning. ClassLink, the leading single sign-on platform for education, and Scrible, an advanced research and writing platform, now integrate using open standards. Read more >>
10Dec